A Korean Postmarketing Study Assessing the Effectiveness of OnabotulinumtoxinA for the Treatment of Neurogenic Detrusor Overactivity or Idiopathic Overactive Bladder Using a Validated Patient-Reported Outcome Measure

PURPOSE: OnabotulinumtoxinA has demonstrated efficacy and safety in the treatment of urinary incontinence (UI) associated with neurogenic detrusor overactivity (NDO) and idiopathic overactive bladder (OAB); however, real-world evidence is limited. This postmarketing surveillance study aimed to asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Ko, Kwang Jin, Jenkins, Brenda, Patel, Anand, Lee, Kyu-Sung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Continence Society 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449655/
https://www.ncbi.nlm.nih.gov/pubmed/30943692
http://dx.doi.org/10.5213/inj.1836176.088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449655/
https://www.ncbi.nlm.nih.gov/pubmed/30943692
http://dx.doi.org/10.5213/inj.1836176.088

Ejemplares similares